Summary
The radioactive 125I-labelled neurotoxin of C. botulinum type A, when incubated with rat brain homogenate, is bound selectively to the synaptosome fraction. Intact toxin was liberated from the synaptosome fraction by treatment with Triton X-100, SDS, trypsin or neuraminidase.
Similar content being viewed by others
References
Brooks, V. B.: An intracellar study of the action of repetitive nerve volleys and of botulinus toxin on miniature end-plate potentials. J. Physiol. (Lond.) 134, 264–277 (1956)
Burgen, A. S. V., Dickens, F., Zatman, L. J.: The action of botulinus toxin in the neuro-muscular junction. J. Physiol. (Lond.) 109, 10–24 (1949)
Cotman, C. W., Levy, W., Banker, G., Taylor, D.: An ultrastructural and chemical analysis of the effect of triton X-100 on synaptic plasma membranes. Biochim. biophys. Acta. (Amst.) 249, 406–418 (1971)
Cotman, C. W., Taylor, D.: Isolation and structural studies on synaptic complexes from rat brain. J. Cell Biol. 55, 696–711 (1972)
DasGupta, B. R., Boroff, D. A., Rothstein, E.: Chromatographic fractionation of crystalline toxin of Clostridium botulinum type A. Biochem. biophys. Res. Commun. 22, 750–756 (1966)
Fiszer, S., De Robertis, E.: Action of triton X-100 on ultrastructure and membrane-bound enzymes of isolated nerve endings from rat brain. Brain Res. 5, 31–44 (1967)
Greenwood, F. C., Hunter, W. V., Glover, J. S.: The preparation of 131I-labelled human growth hormone of high specific radioactivity. Biochem. J. 89, 114–123 (1963)
Habermann, E.: 125I-labelled neurotoxin from Clostridium botulinum type A: Preparation, binding to synaptosomes and ascent to the spinal cord. Naunyn Schmiedeberg's Arch. Pharmacol. 281, 47–56 (1974)
Habermann, E.: Affinity chromatography of tetanus toxin, tetanus toxoid, and botulinum A toxin on synaptosomes, and differentiation of their acceptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 293, 1–9 (1976)
Habermann, E., Heller, I.: Direct evidence for the specific fixation of Cl. botulinum A neurotoxin to brain matter. Naunyn-Schmiedeberg's Arch. Pharmacol. 287, 97–106 (1975)
Hirokawa, N., Kitamura, M.: Localization of radioactive 125I-labelled botulinus toxin at the neuromuscular junction of mouse diaphragm. Naunyn-Schmiedeberg's Arch. Pharmacol. 287, 107–110 (1975)
Kitamura, M., Sakaguchi, S., Sakaguchi, G.: Significance of 12S toxin of Clostridium botulinum type E. J. Bact. 98, 1173–1178 (1969)
Levitan, I. B., Mushyski, W. E., Ramires, G.: Highly purified synaptosomal membranes from rat brain. J. biol. Chem. 247, 5376–5381 (1972)
Polley, E. H., Vick, J. A., Ciuchta, H. P., Fischetti, D. A., Macehitelli, F. J., Montnarell, N.: Botulinum toxin, type A: Effect on central nervous system. Science 147, 1036–1037 (1965)
Whittaker, V. P.: The isolation and characterization of acetylcholine-containing particles from brain. Biochem. J. 72, 694–706 (1959)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kitamura, M. Binding of botulinum neurotoxin to the synaptosome fraction of rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 295, 171–175 (1976). https://doi.org/10.1007/BF00499451
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00499451